Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma — Stella

Recruiting

Back to Soft Tissue Sarcoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Norway

Haukeland University Hospital, Bergen

Oslo University Hospital, Oslo

Key details

Phase

Safety & dosing

Sponsor

Oslo University Hospital

Collaborators

Haukeland University Hospital

Enrollment target

~49 participants

Started

April 2021

Primary completion

September 2026

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov